Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants

Monoclonal antibody therapy is a promising option for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and a cocktail of antibodies (REGN-COV) has been administered to infected patients with a favorable outcome. However, it is necessary to continue generating novel sets of mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Mikako, Iwata-Yoshikawa, Naoko, Matsunaga, Akihiro, Okamura, Tadashi, Saito, Sho, Ashida, Shinobu, Yoshida, Isao, Nagashima, Mami, Asakura, Hiroyuki, Yaoita, Yuu, Suzuki, Jun, Sadamasu, Kenji, Yoshimura, Kazuhisa, Kutsuna, Satoshi, Shiwa-Sudo, Nozomi, Nagata, Noriyo, Suzuki, Tadaki, Suzuki, Akinori, Okamoto, Miwa, Kimura, Moto, Ohmagari, Norio, Miura, Ryu, Ishizaka, Yukihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944172/
https://www.ncbi.nlm.nih.gov/pubmed/35341809
http://dx.doi.org/10.1016/j.antiviral.2022.105297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944172/
https://www.ncbi.nlm.nih.gov/pubmed/35341809
http://dx.doi.org/10.1016/j.antiviral.2022.105297

Ejemplares similares